Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	指定難病告示番号
1	11c-acetate	Acetate	-	-	-	3件: 13, 86, 88 💬
2	[18f]fluoro-2-deoxy-2-d-glucose	D-glucose	1件: D00009 💬	-	-	2件: 86, 88 💬
3	Acetate	Acetate	-	-	-	43件:  1 ,  2 ,  6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬
4	Act-064992	-	-	-	-	5件: 51, 85, 86, 88, 210 💬
5	Act-293987	-	-	-	-	3件: 51, 86, 88 💬
6	Adempas	-	-	-	-	5件: 51, 86, 88, 225, 299 💬
7	Adempas (riociguat, bay63-2521)	Riociguat	1件: D09572 💬	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	2件: 86, 88 💬
8	Adempas®	-	-	-	-	2件: 86, 88 💬
9	Ambrisentan	Ambrisentan	1件: D07077 💬	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	7件: 51, 84, 85, 86, 88, 210, 211 💬
10	Ambrisentan 5 mg	Ambrisentan	1件: D07077 💬	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 88 💬
11	Ammonia	Ammonia	1件: D02916 💬	-	-	4件:  6 , 17, 86, 88 💬
12	Atorvastatin	Atorvastatin	3件: D00258, D00887, D07474 💬	1件: HMGCR 💬	4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis	17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬
13	Barnascan	-	-	-	-	1件: 88 💬
14	Bay 63-2521	-	-	-	-	2件: 86, 88 💬
15	Bay 63-2521 coated tablets 0.5 mg	-	-	-	-	2件: 86, 88 💬
16	Bay 63-2521 coated tablets 1 mg	-	-	-	-	2件: 86, 88 💬
17	Bay 63-2521 coated tablets 1.5 mg	-	-	-	-	2件: 86, 88 💬
18	Bay 63-2521 coated tablets 2 mg	-	-	-	-	2件: 86, 88 💬
19	Bay 63-2521 coated tablets 2.5 mg	-	-	-	-	2件: 86, 88 💬
20	Bay 63-2521 ir coated tablet 1.0 mg	-	-	-	-	1件: 88 💬
21	Bay 63-2521 ir coated tablet 1.5 mg	-	-	-	-	1件: 88 💬
22	Bay 63-2521 ir coated tablet 2.0 mg	-	-	-	-	1件: 88 💬
23	Bay 63-2521 ir coated tablet 2.5 mg	-	-	-	-	1件: 88 💬
24	Bay 63-2521 ir tablet 0.5 mg	-	-	-	-	1件: 88 💬
25	Bay 63-2521 ir tablet 1.0 mg	-	-	-	-	1件: 88 💬
26	Bay 63-2521 ir tablet 1.5 mg	-	-	-	-	1件: 88 💬
27	Bay 63-2521 ir tablet 2.0 mg	-	-	-	-	1件: 88 💬
28	Bay 63-2521 ir tablet 2.5 mg	-	-	-	-	1件: 88 💬
29	Bay 63-2521 tablets 0.5 mg	-	-	-	-	2件: 86, 88 💬
30	Bay 63-2521 tablets 1 mg	-	-	-	-	2件: 86, 88 💬
31	Bay 63-2521 tablets 1.5 mg	-	-	-	-	2件: 86, 88 💬
32	Bay 63-2521 tablets 2 mg	-	-	-	-	2件: 86, 88 💬
33	Bay 63-2521 tablets 2.5 mg	-	-	-	-	2件: 86, 88 💬
34	Bay1237592	-	-	-	-	2件: 86, 88 💬
35	Behavioral: respiratory and exercise therapy	-	-	-	-	1件: 88 💬
36	Behavioral: respiratory and exercise therapy with supplemental oxygen	Oxygen	1件: D00003 💬	-	-	1件: 88 💬
37	Bosentan	Bosentan	2件: D01227, D07538 💬	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
38	Bosentan monohydrate	Bosentan	2件: D01227, D07538 💬	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	4件: 51, 84, 86, 88 💬
39	Bpa	-	-	-	-	1件: 88 💬
40	Cysteine	Cysteine	2件: D00026, D02326 💬	-	-	11件:  6 , 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬
41	D-glucose	D-glucose	1件: D00009 💬	-	-	3件: 49, 86, 88 💬
42	Diagnostic test: endogenous thrombin potential	Thrombin	1件: D00090 💬	-	-	2件: 86, 88 💬
43	Diagnostic test: light transmission aggregometry	-	-	-	-	2件: 86, 88 💬
44	Diagnostic test: platelet function analyzer-100	-	-	-	-	2件: 86, 88 💬
45	Diagnostic test: rotational thromboelastometry	-	-	-	-	2件: 86, 88 💬
46	Edoxaban	Edoxaban	2件: D09546, D09710 💬	1件: F10 💬	1件: Complement and coagulation cascades	2件: 46, 88 💬
47	Fludeoxyglucose	Fludeoxyglucose	1件: D01843 💬	-	-	4件: 34, 84, 85, 88 💬
48	Glucose	Dextrose, unspecified form	-	-	-	15件:  2 ,  6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬
49	Gsk1325760	-	-	-	-	2件: 86, 88 💬
50	Imatinib	Imatinib	2件: D01441, D08066 💬	3件: ABL1, KIT, PDGFRA 💬	31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis	12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
51	Imatinib mesilate	Imatinib	2件: D01441, D08066 💬	3件: ABL1, KIT, PDGFRA 💬	31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis	3件: 13, 86, 88 💬
52	Iodine	Iodine	1件: D00108 💬	-	-	2件: 46, 88 💬
53	Jnj-67896062 / act-064992	-	-	-	-	2件: 86, 88 💬
54	Macitentan	Macitentan	1件: D10135 💬	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	5件: 51, 85, 86, 88, 210 💬
55	Macitentan 10 mg	Macitentan	1件: D10135 💬	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	3件: 51, 86, 88 💬
56	Macitentan tablets	Macitentan	1件: D10135 💬	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	2件: 86, 88 💬
57	Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo [3,4-b]pyridine-3-yl]-5-pyrimidinyl(methyl)carb	-	-	-	-	2件: 86, 88 💬
58	Methyl [4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1h-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]meth	-	-	-	-	2件: 86, 88 💬
59	Multihance	-	-	-	-	2件: 86, 88 💬
60	N-acetyl cysteine	Cysteine	2件: D00026, D02326 💬	-	-	7件: 13, 19, 34, 85, 88, 296, 310 💬
61	Ns-304	-	-	-	-	3件: 70, 86, 88 💬
62	Ns-304 placebo	-	-	-	-	2件: 70, 88 💬
63	Opsumit	-	-	-	-	3件: 86, 88, 210 💬
64	Opsumit®	-	-	-	-	3件: 86, 88, 210 💬
65	Oxygen	Oxygen	1件: D00003 💬	-	-	18件:  6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬
66	Oxygen, liquid	Oxygen	1件: D00003 💬	-	-	2件: 86, 88 💬
67	Ph-combination therapy	-	-	-	-	2件: 86, 88 💬
68	Ph-monotherapy	-	-	-	-	2件: 86, 88 💬
69	Placebo	-	-	-	-	26件:  3 ,  5 ,  6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬
70	Procedure: ballon pulmonary angioplasty	-	-	-	-	1件: 88 💬
71	Procedure: balloon pulmonary angioplasty (bpa)	-	-	-	-	1件: 88 💬
72	Procedure: long term oxygen therapy	Oxygen	1件: D00003 💬	-	-	1件: 88 💬
73	Procedure: no gas	-	-	-	-	2件: 86, 88 💬
74	Procedure: pulmonary endarterectomy	-	-	-	-	1件: 88 💬
75	Procedure: pulmonary endarteriectomy	-	-	-	-	1件: 88 💬
76	Procedure: supplemental oxygen via a mask	Oxygen	1件: D00003 💬	-	-	1件: 88 💬
77	Radiation: cardiac pet imaging using f-18-fdg, n-13 ammonia( nh3)	Ammonia	1件: D02916 💬	-	-	1件: 88 💬
78	Radiation: computed tomography lung subtraction iodine mapping	Iodine	1件: D00108 💬	-	-	1件: 88 💬
79	Remodulin	-	-	-	-	2件: 86, 88 💬
80	Remodulin (r)	-	-	-	-	1件: 88 💬
81	Remodulin 10mg/ml 20ml	-	-	-	-	1件: 88 💬
82	Remodulin 1mg/ml 20ml	-	-	-	-	1件: 88 💬
83	Remodulin 2.5mg/ml 20ml	-	-	-	-	1件: 88 💬
84	Remodulin 5mg/ml 20ml	-	-	-	-	1件: 88 💬
85	Riociguat	Riociguat	1件: D09572 💬	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	6件: 51, 84, 86, 88, 225, 299 💬
86	Riociguat (adempas, bay63-2521)	Riociguat	1件: D09572 💬	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	4件: 51, 86, 88, 299 💬
87	Riociguat oral tablet	Riociguat	1件: D09572 💬	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	1件: 88 💬
88	Ro 47-0203	-	-	-	-	4件: 51, 85, 86, 88 💬
89	Sauerstoff	-	-	-	-	2件: 86, 88 💬
90	Selexipag	Selexipag	1件: D09994 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	5件: 51, 70, 84, 86, 88 💬
91	Thrombin	Thrombin	1件: D00090 💬	-	-	2件: 86, 88 💬
92	Tracleer	-	-	-	-	8件: 13, 51, 84, 85, 86, 88, 210, 211 💬
93	Tracleer 125mg 56cpr riv.	-	-	-	-	1件: 88 💬
94	Tracleer*56cpr riv 125mg	-	-	-	-	3件: 51, 86, 88 💬
95	Treprostinil	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	6件: 51, 84, 85, 86, 88, 210 💬
96	Treprostinil sodium	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	3件: 51, 86, 88 💬
97	Uptravi	-	-	-	-	3件: 84, 86, 88 💬
98	Volibris	-	-	-	-	4件: 51, 85, 86, 88 💬
99	Warfarin	Warfarin	3件: D00564, D01280, D08682 💬	2件: NQO1, VKORC1 💬	6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis	11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬

先頭へ